These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The cage in search of a bird. Kalra S J Assoc Physicians India; 2012 Jan; 60():74-5. PubMed ID: 22715551 [No Abstract] [Full Text] [Related]
8. Pioglitazone and the risk of bladder cancer. Hillaire-Buys D; Faillie JL BMJ; 2012 May; 344():e3500. PubMed ID: 22653979 [No Abstract] [Full Text] [Related]
9. Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone. Aschenbrenner DS Am J Nurs; 2017 Apr; 117(4):25. PubMed ID: 28333739 [No Abstract] [Full Text] [Related]
10. Pioglitazone Use and Risk of Bladder Cancer. Davies BJ JAMA; 2015 Dec; 314(23):2568. PubMed ID: 26670977 [No Abstract] [Full Text] [Related]
11. Pioglitazone Use and Risk of Bladder Cancer. Singh S; Suchard MA JAMA; 2015 Dec; 314(23):2567-8. PubMed ID: 26670976 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM. Perez A; Zhao Z; Jacks R; Spanheimer R Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910 [TBL] [Abstract][Full Text] [Related]
13. Pioglitazone--when is a prescription drug safe? Loke YK; Mattishent K Nat Rev Urol; 2015 Dec; 12(12):655-6. PubMed ID: 26416647 [No Abstract] [Full Text] [Related]
14. Balancing the risks and benefits for pioglitazone in type 2 diabetes. Johnson JA; Colmers IN Diabetes Res Clin Pract; 2012 Oct; 98(1):1-2. PubMed ID: 22959125 [No Abstract] [Full Text] [Related]
15. Pioglitazone Use and Risk of Bladder Cancer--Reply. Ferrara A; Lewis JD; Habel LA JAMA; 2015 Dec; 314(23):2568-9. PubMed ID: 26670978 [No Abstract] [Full Text] [Related]
16. Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study. Goyal A; Singh H; Sehgal VK; Jayanthi CR; Munshi R; Bairy KL; Kumar R; Kaushal S; Kakkar AK; Ambwani S; Goyal C; Mazumdar G; Adhikari A; Das N; Stephy DJ; Thangaraju P; Dhasmana DC; Rehman SU; Chakrabarti A; Bhandare B; Badyal DK; Kaur I; Chandrashekar K; Singh J; Dhamija P; Sarangi SC; Gupta YK Indian J Med Res; 2017 Oct; 146(4):468-475. PubMed ID: 29434060 [TBL] [Abstract][Full Text] [Related]
17. [Thiazolidindiones in type II diabetes mellitus]. Bornkessel B Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974 [No Abstract] [Full Text] [Related]
18. No strong association is found between pioglitazone and bladder cancer. Wise J BMJ; 2015 Jul; 351():h3934. PubMed ID: 26202496 [No Abstract] [Full Text] [Related]
19. Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes. Dorkhan M; Lantz M; Frid A; Groop L; Hallengren B Clin Endocrinol (Oxf); 2006 Jul; 65(1):35-9. PubMed ID: 16817816 [TBL] [Abstract][Full Text] [Related]
20. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]